A Randomized Double‐Blind Crossover Study of the Antiobesity Effects of Etiocholanedione

Obesity Research

Volumn 2, Issue 1, 1994, Pages 13-18

  Zumoff, Bamett ^a,b   Strain, Gladys W ^a,b   Heymsfield, Steven B ^a,b   Lichtman, Steven ^a,b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

antiobesity drugs; clinical trials; etiocholanedione; obesity

Indexed keywords

ANTIOBESITY AGENT; DRUG DERIVATIVE; PRASTERONE;

ADULT; AGED; BODY COMPOSITION; BODY WEIGHT; BOOK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTI-OBESITY AGENTS; BODY COMPOSITION; BODY WEIGHT; CROSS-OVER STUDIES; DEHYDROEPIANDROSTERONE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY;

EID: 0002126956     PISSN: 10717323     EISSN: 15508528     Source Type: Journal    
DOI: 10.1002/j.1550-8528.1994.tb00038.x     Document Type: Article

References (13)

1. An underwater weighing system utilizing “force cube” transducers
2. vy), and normal mice
3. The abdomen‐hip ratio: Normative data and observations on selected patients
4. The effects of oral dehydroepiandrosterone on endocrine‐metabolic parameters in postmenopausal women
5. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men
6. The relationship of weight‐height indexes of obesity to body fat content
7. Cortisol production in obesity
8. Lack of effect of dehydroepiandrosterone in obese men
9. Failure of dehy droepiandrosterone to influence energy and protein metabolism in humans
10. Prevention of obesity in AVYIA mice by dehydroepiandrosterone